KOgllagq
ee
510(k}) SUMMARY
1, Submitter Name and Address JUL 28 2008
SurgRx, Inc.
101 Saginaw Drive
Redwood City, CA 94063
Contact: Linda Oleson
Phone: (650) 482-2400 ext 107
Date: 6/13/08
2. Device Name
Trade name: EnSeal PowerTip with EnSeal Universal
Common name: Electrosurgical open and laparoscopic instruments and accessories
Classification name: Electrosurgical Cutting and Coagulation Device and Accessories
(per 21 CFR section 878.4400) and Gynecologic Electrocautery and Accessories (per
21 CFR 884.4120).
3. Predicate Devices
EnSeal Vessel Sealing and Hemostasis System: k031133, k043008, k050671,
k061526, k062949, k063097, k070165, kO70896, kO72177, k072493, LigaSure
Advance: k063195, Gyrus Bipolar Needle Electrode: k031079, ValieyLab ForceTriad:
k051644.
4. Device Description
EnSeal PowerTip with EnSeal Universal. The functionality of the devices are the same
as the predicate devices.
5. Intended Use
The EnSeal PowerTip with EnSeal Universal generator is intended for use during open
or laparoscopic general and gynecologic surgery to cut and seal vessels, cut, grasp
and dissect tissue and/or seal vessels during surgery. The cutting tip feature is
intended for use in the dissection of tissue planes and the creation of enterotomies and
gastrotomies. The SurgRx EnSeal PowerTip with EnSeal Universal has not been
shown to be effective for tubal sterilization or tubal coagulation for sterilization
procedures. Do not use this system for these procedures.
6. Technological Characteristics
The EnSeal PowerTip with EnSeal Universal generator is the same as the predicate
devices in that they are electrosurgical instruments with monopolar and bipolar
capabilities.
7. Performance Data
Preclinical laboratory (bench) and performance tests were executed to ensure the
. devices function as intended and meet design specifications.
8. Conclusions
Based on performance testing and functional similarities to the predicate devices, we
believe the EnSeal PowerTip with EnSeal Universal generator devices are safe and
effective and substantially equivalent to the predicate devices.
ww
Section 5- 2

S ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
om Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
SurgRX, Inc.
% Ms. Linda Oleson
Director of Clinical & Regulatory Affairs
Consultant JUL 2 8 2008
101 Sawinaw Drive
Redwood City, California 94063
Re: K081129
Trade/Device Name: EnSeal PowerTip with EnSeal Universal
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: June 13, 2008
Received: June 17, 2008
Dear Ms, Oleson:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Linda Oleson
This letter will allow you to begin marketing your device as described in your Section 510(k)

/ premarket notification, The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance at
(240) 276-0115, Also, please note the regulation entitled, “"Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions regarding postmarket surveillance,
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket
Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events
(Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems
at (240) 276-3464. You may obtain other general information on your responsibilities under the
Act from the Division of Small Manufacturers, International and Consumer Assistance
at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
http://Awww.fda.gov/cedrh/industry/support/index.html.

Sincerely yours,

Mark N. Melkerson

Director

: Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

Indications for Use Statement

Applicant: SurgRx, Inc.

510(k) number (if known): K081129

Device Name: EnSeal PowerTip with EnSeal Universal

Indications for Use:
The EnSeal PowerTip is an electrosurgical instrument for use with the EnSeal Universal
electrosurgical generator. It is intended for use during open or laparoscopic, general and
gynecologic surgery to cut and seal vessels, cut, grasp and dissect tissue during surgery.
Indications for use include open and laparoscopic general and gynecological surgical
procedures (including urologic, thoracic, plastic and reconstructive, bowel resections,
hysterectomies, cholecystectomies, gall bladder procedures, Nissen fundoplication,
adhesiolysis, oophorectomies), or any procedure where vessel ligation (cutting and
sealing), tissue grasping and dissection is performed. The devices can be used on
vessels up to (and including) 7 mm and bundles as large’as will fit in the jaws of the
instruments.
The cutting tip feature is intended for use in the dissection of tissue planes and the
creation of enterotomies and gastrotomies.
The EnSeal PowerTip has not been shown to be effective for tubal sterilization or tubal
coagulation for sterilization procedures. Do not use this system for these procedures.

Prescription Use_ X_. AND/OR Over-The-Counter Use.

(Per 21 CFR 801 Subpart D) (Per 21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE — CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)

‘Division Sign-OF
Division of General, Restorative,
and Neurological Devices Page tof 1
s10(k) Number_ KOSN2T
Section 4 -2

